[1] Miller-Fleming L, Olin-Sandoval V, Campbell K, et al. Remaining mysteries of molecular biology:the role of polyamines in the cell[J]. J Mol Biol, 2015, 427(21):3389-3406. [2] Mastracci TL, Robertson MA, Mirmira RG, et al. Polyamine biosynthesis is critical for growth and differentiation of the pancreas[J]. Sci Rep, 2015, 5:13269. [3] Keren-Paz A, Bercovich Z, Porat Z, et al. Overexpression of antizyme-inhibitor in NIH3T3 fibroblasts provides growth advantage through neutralization of antizyme functions[J]. Oncogene, 2006, 25(37):5163-5172. [4] Choi KS1, Suh YH, Kim WH, et al. Stable siRNA-mediated silencing of antizyme inhibitor:regulation of ornithine decarboxylase activity[J]. Biochem Biophys Res Commun, 2005, 328(1):206-212. [5] Murakami Y, Suzuki J, Samejima K, et al. The change of antizyme inhibitor expression and its possible role during mammalian cell cycle[J]. Exp Cell Res, 2009, 315:2301-2311. [6] Mangold U, Hayakawa H, Coughlin M, et al. Antizyme, a mediator of biquitin-independent proteasomal degradation and its inhibitor localize to centrosomes and modulate centriole amplification[J]. Oncogene, 2008, 27(5):604-613. [7] Duensing S. Analysis of centrosomes in human cancer[J]. Methods Cell Biol, 2015, 129:51-60. [8] Kusano T, Berberich T, Tateda C, et al. Polyamines:essential factors for growth and survival[J]. Planta, 2008, 228(3):367-381. [9] Casero RA, Marton LJ. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases[J]. Nature Reviews Drug Discovery, 2007, 6(5):373-390. [10] Olsen RP, Zetter BR. Evidence of a role for antizyme and antizyme imhibitor as regulators of human cancer[J]. Mol Cancer Res, 2011, 9(10):1285-1293. |